‘A mess across the board’: Senate committee kicks off talks on drug pricing reforms

Zachary Brennan

Senior Editor

The US is still the only country in the world that doesn’t negotiate pharmaceutical prices across the board, experts told a Senate committee on Tuesday …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

‘A mess across the board’: Senate committee kicks off talks on drug pricing reforms

Zachary Brennan

Senior Editor

Sign up to read this article for free.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

BridgeBio shares promising results in trial of Canavan disease gene therapy

CRISPR therapy reduces swelling attacks by 81% in Intellia follow-up study

Facing lost rebates, MGM Resorts to stop covering GLP-1 weight loss shots

Exclusive: University of Toronto spinout raises $53.5M to create new obesity drugs with AI

Icon's quarterly earnings hit by biotech and pharma pullback

IDEAYA Biosciences: Targeting unmet market needs with precision oncology

‘A mess across the board’: Sen­ate com­mit­tee kicks off talks on drug pric­ing re­forms

Senior Editor

Sign up to read this article for free.

Viridian Therapeutics

Waltham, MA, USA

‘A mess across the board’: Senate committee kicks off talks on drug pricing reforms